Aerie Pharmaceuticals reported $51.74M in EBIT for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US $ 51.74M 84.11M
Alimera Sciences ALIM:US $ -2752000 730K
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Novartis NOVN:VX 2.88B 596M
Ophthotech OPHT:US $ -34670000 1.57M
Valeant Pharmaceuticals VRX:CN C$ 453M 36M
Zoetis ZTS:US $ 597M 138M